Strength
150 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00088210224
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
RIFAPENTINEApproval Type
New Drug (NDA)
FDA Application
NDA021024On Market Since
2/8/2017
Pharmacological Classes
Rifamycin Antimycobacterial
Rifamycins
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TALICIA DR 10-250-12.5 MG CAP
Brand
57841115002•RedHill Biopharma Ltd
$4.8567
per EA
XIFAXAN 200 MG TABLET
Brand
65649030103•Salix Pharmaceuticals Inc.
$10.7162
per EA
XIFAXAN 550 MG TABLET
Brand
65649030302•Salix Pharmaceuticals Inc.
$55.2802
per EA
XIFAXAN 550 MG TABLET
Brand
65649030303•Salix Pharmaceuticals Inc.
$55.2802
per EA